Stockscreener 앱 받기
7.77
2.51%
0.19
시간 외 거래:
7.77
전일 마감가:
$7.58
열려 있는:
$7.79
하루 거래량:
140.82K
Relative Volume:
0.98
시가총액:
$265.37M
수익:
$21.25M
순이익/손실:
$-16.05M
주가수익비율:
-12.74
EPS:
-0.61
순현금흐름:
$-17.14M
1주 성능:
+1.17%
1개월 성능:
+1.70%
6개월 성능:
-12.60%
1년 성능:
+27.80%
1일 변동 폭
$7.71
$8.11
1주일 범위
$7.35
$8.11
52주 변동 폭
$4.68
$9.92
Fennec Pharmaceuticals Inc Stock (FENC) Company Profile
명칭
Fennec Pharmaceuticals Inc
전화
(919) 636-4530
주소
PO BOX 13628, RESEARCH TRIANGLE PARK, NC
FENC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
FENC
Fennec Pharmaceuticals Inc
|
7.77 | 258.88M | 21.25M | -16.05M | -17.14M | -0.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Fennec Pharmaceuticals Inc Stock (FENC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-11-22 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2022-09-07 | 개시 | CapitalOne | Overweight |
| 2022-08-08 | 재개 | Craig Hallum | Buy |
| 2020-06-05 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-10-11 | 개시 | Goldman | Buy |
Fennec Pharmaceuticals Inc 주식(FENC)의 최신 뉴스
Piper Sandler initiates Fennec Pharmaceuticals stock with Overweight rating - Investing.com India
How Fennec Pharmaceuticals Inc. stock reacts to bond yields2025 Key Lessons & Verified Stock Trade Ideas - ulpravda.ru
Can Fennec Pharmaceuticals Inc. (RV41) stock stage a strong rebound this quarterJuly 2025 Fed Impact & AI Forecast for Swing Trade Picks - ulpravda.ru
Is Fennec Pharmaceuticals Inc. (RV41) stock attractive for growth fundsEarnings Miss & Safe Entry Point Identification - ulpravda.ru
Is Fennec Pharmaceuticals Inc. (RV41) stock a safe buy pre earningsJuly 2025 Patterns & Stepwise Entry and Exit Trade Signals - ulpravda.ru
Published on: 2026-01-08 23:30:09 - ulpravda.ru
Can Fennec Pharmaceuticals Inc. stock continue upward trendJuly 2025 Update & Weekly High Momentum Picks - ulpravda.ru
(FRX) Investment Performance Report (FRX:CA) - Stock Traders Daily
Positive Signs As Multiple Insiders Buy Fennec Pharmaceuticals Stock - Yahoo Finance
(FRX) Pivots Trading Plans and Risk Controls (FRX:CA) - Stock Traders Daily
Aug Final Week: Is Fennec Pharmaceuticals Inc RV41 stock undervalued by metricsTrade Volume Report & Weekly High Return Stock Forecasts - moha.gov.vn
Is Fennec Pharmaceuticals Inc RV41 a good long term investmentStock Split Announcements & High Profit Portfolio Growth - earlytimes.in
Fennec Pharmaceuticals Inc (TSX:FRX) Slipped Under Its Trend Key Levels Matter - Kalkine Media
(FRX) On The My Stocks Page (FRX:CA) - Stock Traders Daily
Fennec Pharmaceuticals (TSE:FRX) Stock Price Passes Below 50-Day Moving AverageHere's Why - MarketBeat
Fennec Pharmaceuticals (TSE:FRX) Stock Price Passes Below 50-Day Moving Average – Here’s Why - Defense World
Aug Opening: Can Fennec Pharmaceuticals Inc RV41 stock stage a strong rebound this quarterPortfolio Gains Summary & Safe Swing Trade Setups - moha.gov.vn
Adherex Technologies (NASDAQ:FENC) Major Shareholder Southpoint Capital Advisors Lp Sells 1,000,000 Shares of Stock - Defense World
(FRX) Proactive Strategies (FRX:CA) - Stock Traders Daily
Southpoint Capital Advisors Lp Sells 1,000,000 Shares of Adherex Technologies (NASDAQ:FENC) Stock - MarketBeat
Fennec Pharmaceuticals Says Southpoint Capital Sold 1 Million Shares - MarketScreener
Southpoint trims stake in Fennec Pharmaceuticals to 8% - MSN
Southpoint holdings in Fennec Pharmaceuticals Inc. (TSX: FENC) - The Manila Times
Southpoint Capital Advisors controls 2.7 million common shares, 8% of outstanding common shares of Fennec - MarketScreener
Southpoint Trims Stake in Fennec Pharmaceuticals to 8% - TipRanks
Southpoint holdings in Fennec Pharmaceuticals Inc. (TSX: FENC) - GlobeNewswire Inc.
Why (FENC) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Adherex Technologies Inc. (NASDAQ:FENC) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Adherex Technologies Inc. (NASDAQ:FENC) Given Consensus Recommendation of “Hold” by Analysts - Defense World
Fennec Pharmaceuticals: A Compelling Single-Asset Growth Story For 2026 (NASDAQ:FENC) - Seeking Alpha
Is Fennec Pharmaceuticals Inc. stock cheap at current valuation2025 Geopolitical Influence & Reliable Intraday Trade Plans - Улправда
Portfolio Update: How Fennec Pharmaceuticals Inc. stock trades before earningsWatch List & Risk Managed Trade Strategies - Улправда
How Fennec Pharmaceuticals Inc. stock performs after earningsOptions Play & Advanced Swing Trade Entry Alerts - Улправда
Is Fennec Pharmaceuticals Inc. stock recession proofAnalyst Upgrade & Long-Term Safe Return Strategies - Улправда
Can Fennec Pharmaceuticals Inc. (RV41) stock hold up in economic slowdownIPO Watch & Comprehensive Market Scan Insights - Улправда
(FRX) Equity Trading Insights (FRX:CA) - Stock Traders Daily
(FENC) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Fennec Pharmaceuticals (TSX:FRX) Operate Today In Precision Oncology - Kalkine Media
(FRX) Equity Market Report (FRX:CA) - Stock Traders Daily
Fennec Pharmaceuticals (TSE:FRX) Insider Sells C$1,061,087.30 in Stock - MarketBeat
Fennec Pharmaceuticals (TSE:FRX) Insider Sells C$1,799,524.00 in Stock - MarketBeat
Fennec's Pedmarqsi gets nod from U.K. regulators - MSN
Fennec Pharmaceuticals Announces Private Offering to Bolster Financial Position - MSN
(FRX) Risk-Controlled Trading Report (FRX:CA) - Stock Traders Daily
Fennec Pharmaceuticals supports new trial for hearing loss prevention in cancer treatment - MSN
Fennec Pharmaceuticals (TSE:FRX) Share Price Passes Below 50 Day Moving AverageWhat's Next? - MarketBeat
Analysts Offer Insights on Healthcare Companies: Fennec Pharmaceuticals (FENC) and Pfizer (PFE) - The Globe and Mail
How To Trade (FRX) (FRX:CA) - Stock Traders Daily
Stocks in play: Fennec Pharmaceuticals Inc. - Barchart.com
Fennec Announces Trial Investigating Pedmark to Prevent Hearing Loss in Adult Men - marketscreener.com
Fennec Pharmaceuticals Announces Investigator-Sponsored Trial to Be Conducted by City of Hope in Metastatic Tumors - marketscreener.com
Fennec Pharmaceuticals Inc (FENC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Fennec Pharmaceuticals Inc 주식 (FENC) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Raykov Rosty | Director |
Jan 02 '26 |
Option Exercise |
2.45 |
15,598 |
38,215 |
98,332 |
| Raykov Rosty | Director |
Jan 02 '26 |
Sale |
7.60 |
10,312 |
78,371 |
88,020 |
0.90%
자본화:
|
볼륨(24시간):